Results 131 to 140 of about 6,711,797 (295)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Spatio-temporal dynamics of burnt areas in federal Protected Areas in the south-east of European Russia [PDF]

open access: diamond, 2021
С.С. Шинкаренко   +2 more
openalex   +1 more source

Evaluation of Monilinia fructicola on apricot fruits [PDF]

open access: yes, 2019
Monilinia fructicola has been a quarantine pathogen in Europe until 2014; however, the disease risk remains large for Prunus species, because of the continuing spreading around Europe.
Christen, D., Del Cueto, J., Stefani, P.
core  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Cover

open access: yesHistorical Studies on Central Europe, 2021
HSCE Historical Studies on Central Europe
doaj   +2 more sources

Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey [PDF]

open access: bronze, 2014
Yazid Belkacémi   +10 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Update Disturbance‐Resilient Analog ReRAM Crossbar Arrays for In‐Memory Deep Learning Accelerators

open access: yesAdvanced Science
Resistive memory (ReRAM) technologies with crossbar array architectures hold significant potential for analog AI accelerator hardware, enabling both in‐memory inference and training.
Wooseok Choi   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy